{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:41Z","timestamp":1786118921632,"version":"build-2736575974"},"reference-count":195,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/cji.0b013e31818403bc","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T03:08:36Z","timestamp":1224126516000},"page":"793-805","source":"Crossref","is-referenced-by-count":62,"title":["Dendritic Cells: A Critical Player in Cancer Therapy?"],"prefix":"10.1097","volume":"31","author":[{"given":"Anna Karolina","family":"Palucka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Banchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"R2-1-20210227","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"R3-1-20210227","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"R4-1-20210227","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1084\/jem.20071733","article-title":"Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state","volume":"204","author":"Ginhoux","year":"2007","journal-title":"J Exp Med"},{"key":"R5-1-20210227","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2006-03-011353","article-title":"Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine matured DCs in myeloma patients","volume":"108","author":"Banerjee","year":"2006","journal-title":"Blood"},{"key":"R6-1-20210227","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1084\/jem.189.4.611","article-title":"Mobilizing dendritic cells for tolerance, priming, and chronic inflammation","volume":"189","author":"Sallusto","year":"1999","journal-title":"J Exp Med"},{"key":"R7-1-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri701","article-title":"The enemy within: keeping self-reactive T cells at bay in the periphery","volume":"2","author":"Walker","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R8-1-20210227","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nature03886","article-title":"Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus","volume":"436","author":"Watanabe","year":"2005","journal-title":"Nature"},{"key":"R9-1-20210227","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"R10-1-20210227","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL-12 and direct the development of TH1 cells from naive CD4+ T cells","volume":"154","author":"Macatonia","year":"1995","journal-title":"J Immunol"},{"key":"R11-1-20210227","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/eji.1830260323","article-title":"Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells","volume":"26","author":"Heufler","year":"1996","journal-title":"Eur J Immunol"},{"key":"R12-1-20210227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"R13-1-20210227","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"R14-1-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"R15-1-20210227","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","article-title":"Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology","volume":"25","author":"Uhlig","year":"2006","journal-title":"Immunity"},{"key":"R16-1-20210227","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.coi.2005.09.002","article-title":"How do CD4+CD25+ regulatory T cells control autoimmunity?","volume":"17","author":"Bluestone","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R17-1-20210227","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"R18-1-20210227","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","article-title":"The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells","volume":"212","author":"Shevach","year":"2006","journal-title":"Immunol Rev"},{"key":"R19-1-20210227","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","article-title":"Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans","volume":"7","author":"Roncarolo","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R20-1-20210227","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R21-1-20210227","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","article-title":"Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing","volume":"14","author":"Sfanos","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R22-1-20210227","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific TH17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"R23-1-20210227","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI23215","article-title":"IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage","volume":"114","author":"O'Garra","year":"2004","journal-title":"J Clin Invest"},{"key":"R24-1-20210227","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","article-title":"CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production","volume":"188","author":"Thornton","year":"1998","journal-title":"J Exp Med"},{"key":"R25-1-20210227","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20030422","article-title":"Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells","volume":"198","author":"Yamazaki","year":"2003","journal-title":"J Exp Med"},{"key":"R26-1-20210227","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-065X.2001.1820105.x","article-title":"Type 1 T regulatory cells","volume":"182","author":"Roncarolo","year":"2001","journal-title":"Immunol Rev"},{"key":"R27-1-20210227","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"R28-1-20210227","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-065X.2001.1820117.x","article-title":"Induction and mechanism of action of transforming growth factor-beta-secreting TH3 regulatory cells","volume":"182","author":"Weiner","year":"2001","journal-title":"Immunol Rev"},{"key":"R29-1-20210227","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.193.2.233","article-title":"Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells","volume":"193","author":"Dhodapkar","year":"2001","journal-title":"J Exp Med"},{"key":"R30-1-20210227","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","article-title":"Cell biology of antigen processing in vitro and in vivo","volume":"23","author":"Trombetta","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R31-1-20210227","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","article-title":"TNF\/TNFR family members in costimulation of T cell responses","volume":"23","author":"Watts","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R32-1-20210227","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R33-1-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.coi.2005.05.011","article-title":"Levels of complexity in pathogen recognition by C-type lectins","volume":"17","author":"Cambi","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R34-1-20210227","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.immunol.23.021704.115616","article-title":"CATERPILLER: a novel gene family important in immunity, cell death, and diseases","volume":"23","author":"Ting","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R35-1-20210227","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2006.11.005","article-title":"Innate recognition of intracellular bacteria","volume":"19","author":"Delbridge","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"R36-1-20210227","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.it.2005.06.004","article-title":"NLRs join TLRs as innate sensors of pathogens","volume":"26","author":"Martinon","year":"2005","journal-title":"Trends Immunol"},{"key":"R37-1-20210227","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1997","article-title":"Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation","volume":"7","author":"Mariathasan","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R38-1-20210227","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.20050810","article-title":"Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity","volume":"202","author":"Munz","year":"2005","journal-title":"J Exp Med"},{"key":"R39-1-20210227","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat Med"},{"key":"R40-1-20210227","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri1372","article-title":"Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses","volume":"4","author":"Seong","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R41-1-20210227","first-page":"109","article-title":"Stress-induced proteins in immune response to cancer","volume":"167","author":"Srivastava","year":"1991","journal-title":"Curr Top Microbiol Immunol"},{"key":"R42-1-20210227","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R43-1-20210227","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1075565","article-title":"Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2","volume":"298","author":"Biragyn","year":"2002","journal-title":"Science"},{"key":"R44-1-20210227","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00281-004-0173-3","article-title":"Natural endogenous adjuvants","volume":"26","author":"Rock","year":"2005","journal-title":"Springer Semin Immunopathol"},{"key":"R45-1-20210227","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.4049\/jimmunol.177.11.7959","article-title":"Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria","volume":"177","author":"Flacher","year":"2006","journal-title":"J Immunol"},{"key":"R46-1-20210227","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.4049\/jimmunol.178.4.1986","article-title":"Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition","volume":"178","author":"van der Aar","year":"2007","journal-title":"J Immunol"},{"key":"R47-1-20210227","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"R48-1-20210227","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q","article-title":"Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells","volume":"31","author":"Jarrossay","year":"2001","journal-title":"Eur J Immunol"},{"key":"R49-1-20210227","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1084\/jem.20021908","article-title":"Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential Toll-like receptor ligation","volume":"197","author":"Boonstra","year":"2003","journal-title":"J Exp Med"},{"key":"R50-1-20210227","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"R51-1-20210227","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R53-1-20210227","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V90.4.1458","article-title":"CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis","volume":"90","author":"Caux","year":"1997","journal-title":"Blood"},{"key":"R54-1-20210227","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-065X.2007.00551.x","article-title":"Dendritic cell subsets in health and disease","volume":"219","author":"Ueno","year":"2007","journal-title":"Immunol Rev"},{"key":"R55-1-20210227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"R56-1-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.180.1.83","article-title":"Proliferating dendritic cell progenitors in human blood","volume":"180","author":"Romani","year":"1994","journal-title":"J Exp Med"},{"key":"R57-1-20210227","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jlb.64.3.358","article-title":"Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells","volume":"64","author":"Paquette","year":"1998","journal-title":"J Leukoc Biol"},{"key":"R58-1-20210227","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat Immunol"},{"key":"R59-1-20210227","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1084\/jem.194.7.1013","article-title":"Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells","volume":"194","author":"Mohamadzadeh","year":"2001","journal-title":"J Exp Med"},{"key":"R60-1-20210227","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ni760","article-title":"Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4","volume":"3","author":"Chang","year":"2002","journal-title":"Nat Immunol"},{"key":"R61-1-20210227","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL-10-treated dendritic cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol"},{"key":"R62-1-20210227","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0952-7915(03)00015-3","article-title":"The use of dendritic cells in cancer immunotherapy","volume":"15","author":"Schuler","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"R63-1-20210227","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"R64-1-20210227","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMra072739","article-title":"Cancer immunology","volume":"358","author":"Finn","year":"2008","journal-title":"N Engl J Med"},{"key":"R65-1-20210227","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/360258a0","article-title":"GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells","volume":"360","author":"Caux","year":"1992","journal-title":"Nature"},{"key":"R66-1-20210227","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.0502261","article-title":"Rational approaches to human cancer immunotherapy","volume":"73","author":"Davis","year":"2003","journal-title":"J Leukoc Biol"},{"key":"R67-1-20210227","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"Lu","year":"2004","journal-title":"Nat Med"},{"key":"R68-1-20210227","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R69-1-20210227","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2007.00575.x","article-title":"Taming cancer by inducing immunity via dendritic cells","volume":"220","author":"Palucka","year":"2007","journal-title":"Immunol Rev"},{"key":"R70-1-20210227","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00617.x","article-title":"Reengineering dendritic cell-based anti-cancer vaccines","volume":"222","author":"Koski","year":"2008","journal-title":"Immunol Rev"},{"key":"R71-1-20210227","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med"},{"key":"R72-1-20210227","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","article-title":"Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma","volume":"190","author":"Thurner","year":"1999","journal-title":"J Exp Med"},{"key":"R73-1-20210227","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/eji.200636329","article-title":"IL-15-induced human DC efficiently prime melanoma-specific naive CD8(+) T cells to differentiate into CTL","volume":"37","author":"Dubsky","year":"2007","journal-title":"Eur J Immunol"},{"key":"R74-1-20210227","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat Med"},{"key":"R75-1-20210227","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1200\/JCO.2000.18.23.3894","article-title":"Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells","volume":"18","author":"Small","year":"2000","journal-title":"J Clin Oncol"},{"key":"R76-1-20210227","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.1073\/pnas.141226398","article-title":"Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy","volume":"98","author":"Fong","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R77-1-20210227","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00262-005-0106-6","article-title":"Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells","volume":"55","author":"Fay","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"R78-1-20210227","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1074-7613(00)80101-6","article-title":"The makings of a tumor rejection antigen","volume":"11","author":"Gilboa","year":"1999","journal-title":"Immunity"},{"key":"R79-1-20210227","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/14760584.4.5.699","article-title":"Dendritic cells: tools and targets for antitumor vaccination","volume":"4","author":"den Brok","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"R80-1-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20011097","article-title":"Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells","volume":"195","author":"Dhodapkar","year":"2002","journal-title":"J Exp Med"},{"key":"R81-1-20210227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/CJI.0b013e31815a5892","article-title":"Enhanced T-cell responses to glioma cells coated with the anti-EGF receptor antibody and targeted to activating FcgammaRs on human dendritic cells","volume":"31","author":"Banerjee","year":"2008","journal-title":"J Immunother"},{"key":"R82-1-20210227","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"R83-1-20210227","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.192.11.1535","article-title":"Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells","volume":"192","author":"Berard","year":"2000","journal-title":"J Exp Med"},{"key":"R84-1-20210227","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.cji.0000211309.90621.8b","article-title":"Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity","volume":"29","author":"Palucka","year":"2006","journal-title":"J Immunother"},{"key":"R85-1-20210227","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.176.4.2134","article-title":"Hyperthermia enhances CTL cross-priming","volume":"176","author":"Shi","year":"2006","journal-title":"J Immunol"},{"key":"R86-1-20210227","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"R87-1-20210227","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.178.4.1975","article-title":"Unique human tumor antigens: immunobiology and use in clinical trials","volume":"178","author":"Parmiani","year":"2007","journal-title":"J Immunol"},{"key":"R88-1-20210227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.immunol.24.021605.090733","article-title":"Human T cell responses against melanoma","volume":"24","author":"Boon","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"R89-1-20210227","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/IR:36:1:73","article-title":"Human tumor antigens, immunosurveillance, and cancer vaccines","volume":"36","author":"Finn","year":"2006","journal-title":"Immunol Res"},{"key":"R90-1-20210227","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00262-003-0375-x","article-title":"Durable complete clinical responses in a phase I\/II trial using an autologous melanoma cell\/dendritic cell vaccine","volume":"52","author":"O'Rourke","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"R91-1-20210227","first-page":"998","article-title":"Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma","volume":"9","author":"Butterfield","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R92-1-20210227","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","article-title":"The biology of cancer stem cells","volume":"23","author":"Lobo","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R93-1-20210227","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2006.04.006","article-title":"Pten, tumorigenesis, and stem cell self-renewal","volume":"125","author":"Rossi","year":"2006","journal-title":"Cell"},{"key":"R94-1-20210227","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1084\/jem.20062387","article-title":"Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy","volume":"204","author":"Spisek","year":"2007","journal-title":"J Exp Med"},{"key":"R95-1-20210227","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.coi.2004.12.003","article-title":"CD1 assembly and the formation of CD1-antigen complexes","volume":"17","author":"Hava","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R96-1-20210227","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/372691a0","article-title":"Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells","volume":"372","author":"Beckman","year":"1994","journal-title":"Nature"},{"key":"R97-1-20210227","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni827","article-title":"Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs","volume":"3","author":"Fujii","year":"2002","journal-title":"Nat Immunol"},{"key":"R99-1-20210227","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nbt1154","article-title":"Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy","volume":"23","author":"de Vries","year":"2005","journal-title":"Nat Biotechnol"},{"key":"R100-1-20210227","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1084\/jem.20030448","article-title":"Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming","volume":"198","author":"Martin-Fontecha","year":"2003","journal-title":"J Exp Med"},{"key":"R101-1-20210227","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1517\/14712598.8.7.865","article-title":"Maximizing dendritic cell migration in cancer immunotherapy","volume":"8","author":"Verdijk","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"R102-1-20210227","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1158\/1078-0432.CCR-06-1879","article-title":"Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients","volume":"12","author":"Lesimple","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R103-1-20210227","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00262-007-0385-1","article-title":"Introduction of functional chimeric E\/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes","volume":"57","author":"Dorrie","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"R104-1-20210227","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1182\/blood-2001-11-0017","article-title":"Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells","volume":"100","author":"Scandella","year":"2002","journal-title":"Blood"},{"key":"R105-1-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(03)00175-4","article-title":"Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity","volume":"19","author":"Itano","year":"2003","journal-title":"Immunity"},{"key":"R106-1-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20021348","article-title":"Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control","volume":"198","author":"Mullins","year":"2003","journal-title":"J Exp Med"},{"key":"R107-1-20210227","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R108-1-20210227","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri1349","article-title":"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity","volume":"4","author":"Chen","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R109-1-20210227","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1084\/jem.20050072","article-title":"In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses","volume":"201","author":"Shin","year":"2005","journal-title":"J Exp Med"},{"key":"R110-1-20210227","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2006.01.011","article-title":"Principles and use of anti-CTLA4 antibody in human cancer immunotherapy","volume":"18","author":"Peggs","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"R111-1-20210227","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J Exp Med"},{"key":"R112-1-20210227","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20061660","article-title":"Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand","volume":"204","author":"Ito","year":"2007","journal-title":"J Exp Med"},{"key":"R113-1-20210227","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/16717","article-title":"ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28","volume":"397","author":"Hutloff","year":"1999","journal-title":"Nature"},{"key":"R114-1-20210227","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/89739","article-title":"ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses","volume":"2","author":"Gonzalo","year":"2001","journal-title":"Nat Immunol"},{"key":"R115-1-20210227","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/35051107","article-title":"ICOS is critical for CD40-mediated antibody class switching","volume":"409","author":"McAdam","year":"2001","journal-title":"Nature"},{"key":"R116-1-20210227","doi-asserted-by":"crossref","first-page":"13138","DOI":"10.1073\/pnas.0603107103","article-title":"OX40 ligand shuts down IL-10-producing regulatory T cells","volume":"103","author":"Ito","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R117-1-20210227","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1084\/jem.20071341","article-title":"OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection","volume":"205","author":"Piconese","year":"2008","journal-title":"J Exp Med"},{"key":"R118-1-20210227","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J Exp Med"},{"key":"R119-1-20210227","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20061120","article-title":"Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development","volume":"204","author":"Aspord","year":"2007","journal-title":"J Exp Med"},{"key":"R120-1-20210227","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coi.2007.04.012","article-title":"PD-1 and its ligands in T-cell immunity","volume":"19","author":"Keir","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"R121-1-20210227","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"R122-1-20210227","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","volume":"203","author":"Keir","year":"2006","journal-title":"J Exp Med"},{"key":"R123-1-20210227","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1\u2013PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J Exp Med"},{"key":"R124-1-20210227","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"R125-1-20210227","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"R126-1-20210227","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat Immunol"},{"key":"R127-1-20210227","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/eji.200635978","article-title":"Contribution of the PD-1 ligands\/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation","volume":"36","author":"Kuipers","year":"2006","journal-title":"Eur J Immunol"},{"key":"R128-1-20210227","first-page":"6451","article-title":"Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine","volume":"61","author":"Banchereau","year":"2001","journal-title":"Cancer Res"},{"key":"R129-1-20210227","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20032118","article-title":"Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells","volume":"199","author":"Paczesny","year":"2004","journal-title":"J Exp Med"},{"key":"R130-1-20210227","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.21.120601.141045","article-title":"On natural and artificial vaccinations","volume":"21","author":"Zinkernagel","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"R131-1-20210227","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J Virol"},{"key":"R132-1-20210227","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1257","article-title":"Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination","volume":"11","author":"Badovinac","year":"2005","journal-title":"Nat Med"},{"key":"R133-1-20210227","first-page":"8643","article-title":"Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma","volume":"61","author":"Steitz","year":"2001","journal-title":"Cancer Res"},{"key":"R134-1-20210227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(03)00359-5","article-title":"Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"},{"key":"R135-1-20210227","doi-asserted-by":"crossref","first-page":"20884","DOI":"10.1073\/pnas.0710557105","article-title":"Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma","volume":"104","author":"Vence","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R136-1-20210227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0065-2776(08)60575-1","article-title":"The murine antitumor immune response and its therapeutic manipulation","volume":"35","author":"North","year":"1984","journal-title":"Adv Immunol"},{"key":"R137-1-20210227","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/eji.200324034","article-title":"Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution","volume":"33","author":"Ma","year":"2003","journal-title":"Eur J Immunol"},{"key":"R138-1-20210227","first-page":"1671","article-title":"Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells","volume":"48","author":"Berd","year":"1988","journal-title":"Cancer Res"},{"key":"R139-1-20210227","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI25947","article-title":"Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells","volume":"115","author":"Dannull","year":"2005","journal-title":"J Clin Invest"},{"key":"R141-1-20210227","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/ijc.22617","article-title":"Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro","volume":"120","author":"Mahnke","year":"2007","journal-title":"Int J Cancer"},{"key":"R142-1-20210227","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni1205-1207","article-title":"Breaking down the barriers to cancer immunotherapy","volume":"6","author":"Pure","year":"2005","journal-title":"Nat Immunol"},{"key":"R143-1-20210227","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R144-1-20210227","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0065-2776(06)90008-X","article-title":"Checkpoint blockade in cancer immunotherapy","volume":"90","author":"Korman","year":"2006","journal-title":"Adv Immunol"},{"key":"R145-1-20210227","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-065X.2008.00604.x","article-title":"Twelve immunotherapy drugs that could cure cancers","volume":"222","author":"Cheever","year":"2008","journal-title":"Immunol Rev"},{"key":"R146-1-20210227","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R147-1-20210227","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R148-1-20210227","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/82771","article-title":"NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway","volume":"1","author":"Terabe","year":"2000","journal-title":"Nat Immunol"},{"key":"R149-1-20210227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"R150-1-20210227","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nri1498","article-title":"Mechanisms and functional significance of tumour-induced dendritic-cell defects","volume":"4","author":"Gabrilovich","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R151-1-20210227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"R152-1-20210227","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrc2051","article-title":"Immunostimulatory monoclonal antibodies for cancer therapy","volume":"7","author":"Melero","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R153-1-20210227","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat Biotechnol"},{"key":"R154-1-20210227","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.coi.2007.04.015","article-title":"Cytokines and T-cell homeostasis","volume":"19","author":"Boyman","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"R155-1-20210227","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1172\/JCI200523134","article-title":"Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool","volume":"115","author":"Melchionda","year":"2005","journal-title":"J Clin Invest"},{"key":"R156-1-20210227","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","article-title":"IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells","volume":"29","author":"Rosenberg","year":"2006","journal-title":"J Immunother (1997)"},{"key":"R157-1-20210227","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1150","article-title":"Cancer vaccines: between the idea and the reality","volume":"3","author":"Finn","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R158-1-20210227","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.022634999","article-title":"Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery","volume":"99","author":"Asavaroengchai","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R159-1-20210227","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1172\/JCI32205","article-title":"Microbial translocation augments the function of adoptively transferred self\/tumor-specific CD8 T cells via TLR4 signaling","volume":"117","author":"Paulos","year":"2007","journal-title":"J Clin Invest"},{"key":"R160-1-20210227","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J Clin Oncol"},{"key":"R161-1-20210227","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.cdd.4402247","article-title":"Interactions of tumor cells with dendritic cells: balancing immunity and tolerance","volume":"15","author":"Dhodapkar","year":"2008","journal-title":"Cell Death Differ"},{"key":"R162-1-20210227","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1158\/1078-0432.CCR-07-2245","article-title":"Capitalizing on the immunogenicity of dying tumor cells","volume":"14","author":"Fonseca","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R163-1-20210227","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J Exp Med"},{"key":"R164-1-20210227","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1182\/blood-2006-10-054221","article-title":"Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications","volume":"109","author":"Spisek","year":"2007","journal-title":"Blood"},{"key":"R165-1-20210227","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/0008-5472.CAN-08-0427","article-title":"Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies","volume":"68","author":"Apetoh","year":"2008","journal-title":"Cancer Res"},{"key":"R166-1-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2007.00573.x","article-title":"The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy","volume":"220","author":"Apetoh","year":"2007","journal-title":"Immunol Rev"},{"key":"R167-1-20210227","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-065X.2007.00567.x","article-title":"Ecto-calreticulin in immunogenic chemotherapy","volume":"220","author":"Obeid","year":"2007","journal-title":"Immunol Rev"},{"key":"R168-1-20210227","first-page":"228","article-title":"Local administration of dendritic cells inhibits established breast cancer growth: implications for apoptosis inducing agents","volume":"61","author":"Candido","year":"2001","journal-title":"Cancer Res"},{"key":"R169-1-20210227","first-page":"7530","article-title":"Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors","volume":"61","author":"Tong","year":"2001","journal-title":"Cancer Res"},{"key":"R170-1-20210227","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1158\/0008-5472.CAN-05-0406","article-title":"Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells","volume":"65","author":"Song","year":"2005","journal-title":"Cancer Res"},{"key":"R171-1-20210227","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","article-title":"Macrophage polarization comes of age","volume":"23","author":"Mantovani","year":"2005","journal-title":"Immunity"},{"key":"R172-1-20210227","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"key":"R173-1-20210227","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-07-0892","article-title":"Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment","volume":"13","author":"Gajewski","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R174-1-20210227","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1158\/0008-5472.CAN-07-5008","article-title":"Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration","volume":"68","author":"Janicki","year":"2008","journal-title":"Cancer Res"},{"key":"R175-1-20210227","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.179.8.4969","article-title":"Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 TH cells at tumor sites","volume":"179","author":"Chaput","year":"2007","journal-title":"J Immunol"},{"key":"R176-1-20210227","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8(+) T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat Med"},{"key":"R177-1-20210227","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1158\/0008-5472.CAN-06-4174","article-title":"Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells","volume":"67","author":"Sinha","year":"2007","journal-title":"Cancer Res"},{"key":"R178-1-20210227","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI28828","article-title":"Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells","volume":"116","author":"Gallina","year":"2006","journal-title":"J Clin Invest"},{"key":"R179-1-20210227","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-065X.2008.00602.x","article-title":"Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells","volume":"222","author":"Marigo","year":"2008","journal-title":"Immunol Rev"},{"key":"R180-1-20210227","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.20041684","article-title":"Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors","volume":"201","author":"Yu","year":"2005","journal-title":"J Exp Med"},{"key":"R181-1-20210227","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1158\/0008-5472.CAN-05-1319","article-title":"Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses","volume":"65","author":"Dercamp","year":"2005","journal-title":"Cancer Res"},{"key":"R182-1-20210227","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20022227","article-title":"Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence","volume":"198","author":"Terabe","year":"2003","journal-title":"J Exp Med"},{"key":"R183-1-20210227","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J Clin Invest"},{"key":"R184-1-20210227","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00262-005-0703-4","article-title":"Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression","volume":"54","author":"Sinha","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"R185-1-20210227","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","article-title":"Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression","volume":"16","author":"Serafini","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"R186-1-20210227","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature05768","article-title":"Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands","volume":"447","author":"Kaiser","year":"2007","journal-title":"Nature"},{"key":"R187-1-20210227","first-page":"121","article-title":"Immunobiology of human NKG2D and its ligands","volume":"298","author":"Gonzalez","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"R188-1-20210227","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molimm.2004.07.038","article-title":"Helper role of NK cells during the induction of anticancer responses by dendritic cells","volume":"42","author":"Kalinski","year":"2005","journal-title":"Mol Immunol"},{"key":"R189-1-20210227","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.coi.2005.05.007","article-title":"Gene profiling of immune responses against tumors","volume":"17","author":"Wang","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R190-1-20210227","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help","volume":"300","author":"Sun","year":"2003","journal-title":"Science"},{"key":"R191-1-20210227","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.coi.2004.05.004","article-title":"CD8+ T-cell memory: only the good ones last","volume":"16","author":"Northrop","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"R192-1-20210227","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes","volume":"23","author":"Kronenberg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R193-1-20210227","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35095564","article-title":"Natural killer cells, viruses and cancer","volume":"1","author":"Cerwenka","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"R194-1-20210227","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat Med"},{"key":"R195-1-20210227","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm0904-887","article-title":"Cancer immunotherapy: breaking the barriers to harvest the crop","volume":"10","author":"Pardoll","year":"2004","journal-title":"Nat Med"},{"key":"R196-1-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.cji.0000211341.88835.ae","article-title":"A clinical development paradigm for cancer vaccines and related biologics","volume":"30","author":"Hoos","year":"2007","journal-title":"J Immunother"},{"key":"R197-1-20210227","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/annonc\/mdj138","article-title":"Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG","volume":"17","author":"Schadendorf","year":"2006","journal-title":"Ann Oncol"},{"key":"R198-1-20210227","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/JVI.02343-07","article-title":"Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial","volume":"82","author":"Santin","year":"2008","journal-title":"J Virol"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e31818403bc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:08:30Z","timestamp":1786036110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200811000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":195,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e31818403bc","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}